Stabilizing progressive vitiligo with systemic treatment

Published: 15 March 2024| Version 1 | DOI: 10.17632/mgk5526yw2.1
Contributor:
Ting-Ting Yang

Description

This study evaluates the clinical features of vitiligo patients requiring prolonged or multiple courses of systemic immunosuppressants to control disease activity.

Files

Categories

Dermatology, Vitiligo

Licence